Cannabidiol (CBD) is evolving into a mainstream consumer product. CBD won’t make you high, but it can make you rich. Read More
Marijuana Investing
Psychedelics such as magic mushrooms are poised to play key roles in medicine and psychiatry. There’s big money in those fungi. Read More
Your questions covered a range of pot-related topics, from Mastercard's new anti-weed policy to Biden's change of heart to micro-cap pitfalls. Read More
A new study shows that states with legalized adult-use marijuana have witnessed a dramatic drop in mental health treatment admissions. Read More
Congressional lawmakers this week are pushing an amendment to an appropriations bill that would facilitate research into psychedelics. Read More
Republicans are pushing a bill in Congress to lift federal restrictions on marijuana, further proof that the "green rush" is alive and well. Read More
The campaign to lift restrictions on “magic mushrooms" has been cleared to collect signatures for a 2024 ballot Initiative in California. Read More
A new report reveals the diversity of pot consumers and their changing tastes, preferences, and habits. Here’s what investors need to know. Read More
The consumer base for marijuana is growing around the globe, especially in North America. Read More
Congress has added several reform amendments to the latest defense funding bill, affecting such substances as marijuana, LSD, and psilocybin. Read More